BeiGene, Ltd. (BGNE)
NASDAQ: BGNE · Real-Time Price · USD
190.51
-4.05 (-2.08%)
Nov 22, 2024, 4:00 PM EST - Market closed
BeiGene Market Cap
BeiGene has a market cap or net worth of $20.24 billion as of November 22, 2024. Its market cap has decreased by -3.26% in one year.
Market Cap
20.24B
Enterprise Value
18.58B
1-Year Change
-3.26%
Ranking
Category
Stock Price
$190.51
Market Cap Chart
Since February 3, 2016, BeiGene's market cap has increased from $861.90M to $20.24B, an increase of 2,248.41%. That is a compound annual growth rate of 43.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 20.71B | 9.81% |
| Dec 29, 2023 | 18.86B | -17.40% |
| Dec 30, 2022 | 22.83B | -10.17% |
| Dec 31, 2021 | 25.41B | 8.12% |
| Dec 31, 2020 | 23.50B | 133.90% |
| Dec 31, 2019 | 10.05B | 20.62% |
| Dec 31, 2018 | 8.33B | 87.56% |
| Dec 29, 2017 | 4.44B | 342.97% |
| Dec 30, 2016 | 1.00B | 16.34% |
| Feb 3, 2016 | 861.90M | - |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Natera | 22.36B |
| Waters | 21.88B |
| Illumina | 21.73B |
| Zimmer Biomet Holdings | 21.58B |
| STERIS | 21.30B |
| Labcorp Holdings | 20.09B |
| The Cooper Companies | 19.90B |
| Teva Pharmaceutical | 19.35B |